bronchiolitis Respiratory syncytial virus infection
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
2 Years to 11 Years
Inclusion criteria
Inclusion criteria: Index group (n
Exclusion criteria
Exclusion criteria: * Previous airway morbidity in all groups * Severe co-morbidity (p.e. congenital heart disease, prematurity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An undiluted nasopharyngeal aspirate (NPA) will be taken within 1 hour before intubation followed by an endotracheal aspirate (ETA) at 6, 24 and 48 hours after intubation. In non-intubated patients a NPA will be taken at 0, 6, 24 and 48 hours after the first NPA. Cytokine concentrations in NPA /ETA will be determined; IL-1, IL-6, TNF-*, IL-10 and IL-8 will be measured using the Luminex fluorescent-bead-based technology. Of the ventilated patients, 2 ml blood will be collected every 48 hours for immunological studies. | — |
Countries
Netherlands
Outcome results
None listed